Abstract
The cytochrome CYP1A1 gene has been implicated in the etiology of oral cancer. However, the results have been inconsistent. In this study, a meta-analysis was performed to clarify the associations of polymorphisms in CYP1A1 gene with oral cancer risk. Published literatures from PubMed, MEDLINE, EMBASE, and China National Knowledge infrastructure (CNKI) databases were retrieved. A total of 12 studies were included in this meta-analysis. We found that significant positive associations between CYP1A1*2A polymorphism and oral cancer risk in recessive model (CC vs. TC + TT, OR = 1.93), dominant model (CC + TC vs. TT, OR = 1.33), and additive model (CC vs. TT, OR = 1.97). In subgroup analysis based on the ethnicity of study population, significant associations were found in all three genetic models for Asians (recessive OR = 2.29, 95 % CI = 1.42–3.71; dominant OR = 1.54, 95 % CI = 1.03–2.31; additive OR = 2.39, 95 % CI = 1.47–3.88) but not non-Asians. For the smoking stratification, the result indicated a significant association between CYP1A1*2A polymorphism and oral cancer among the smoking subjects (OR = 1.83, 95 % CI = 1.47–2.26). This meta-analysis indicated a marked association of CYP1A1*2A polymorphisms with oral cancer risk, particularly among Asians, whereas there were significant interactions between the polymorphisms and cigarette smoking on oral cancer risk.
Similar content being viewed by others
References
Zygogianni AG, Kyrgias G, Karakitsos P, Psyrr A, Kouvars J, Kelekis N, et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011;3:2.
Reichart PA, Nguyen XH. Betel qud chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med. 2008;37:511–4.
Nerurkar PV, Okinaka L, Aoki C, Seifried A, Lum-Jones A, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev. 2000;9:1119–22.
Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400:201–13.
Masson LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol. 2005;161:901–15.
Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Genet. 1991;48:720–5.
Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol. 1999;35:191–6.
Balaji L, Singh KB, Bhaskar LV. CYP1A1 genotypes and haplotypes and risk of oral cancer: a case-control study in South Indians. Genet Mol Biol. 2012;35(2):407–12.
Moher D, Liberati A, Tetzlaff J, Altman DG. the PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003;49:1–6.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Egger M, Davey Smith G, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–34.
Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, et al. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol. 2001;37:593–8.
Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, et al. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med. 2002;31:505–11.
Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 2003;9:62–7.
Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28:819–26.
Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 2007;28:1455–62.
Cha IH, Park JY, Chung WY, Choi MA, Kim HJ, et al. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J. 2007;48:233–9.
Losi-Guembarovski R, Colus IM, De Menezes RP, Poliseli F, Chaves VN, et al. Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res. 2008;28:1023–8.
Cordero K, Espinoza I, Caceres D, Roco A, Miranda C, et al. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. Oral Lett. 2010;1:549–33.
Chatterjee S, Dhar S, Sengupta B, Ghosh A, De M, et al. Polymorphisms of CYP1A1, GSTM1 and GSTT1 loci as the genetic predispositions of oral cancers and other oral pathologies: tobacco and alcohol as risk modifiers. Indian J Clin Biochem. 2010;25:260–72.
Deepika S, Alka Dinesh K, Seema H, Subbiah V, Yerrmalla V. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Rap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156(3):253–9.
Guo L, Zhang C, Shi S, Guo X. Correlation between smoking and the polymorphisms of cytochrome P450 1A1-Msp I and glutathione S-trans-ferase T1 genes and oral cancer. West China J Stomatology. 2012;2:30.
Singh RD, Haridas N, Shah FD, Patel JB, Shukla SN, et al. Gene polymorphisms, tobacco exposure and oral cancer susceptibility: a study from Gujarat. West India Oral Dis. 2014;20:84–93.
Zheng Y, Wang JJ, Sun L, Li HL. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep. 2011; doi: 10.1007/s11033-011-1126-2
Chen Z, Li Z, Niu X, Ye X, Yu Y, et al. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis. 2011;26:437–46.
Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:459–69.
Shaik AP, Jamil K, Das P. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J. 2009;6:78–86.
Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67–79.
Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol. 2008;32:945–73.
Devasena A, Amelie C, Valerie G, Silvia F, Rolando H, et al. Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India. PLOS ONE. 2014;9(2):e88240.
Zhuo X, Zhao H, Chang A, Zhou Y, et al. Quantitative Assessment of CYP1A1*2A variation with oral carcinoma susceptibility: evidence from 1,438 cases and 2,086 controls. Cancer Investig. 2012;30:552–9.
Wacholder S, Silverman DT, Mclaughlin JK, Mandel JS. Selection of controls in case-control studies II. Types of controls. Am J Epidemiol. 1992;135:1029–41.
Conflicts of interests
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, KT., Ge, C., Xu, XF. et al. CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies. Tumor Biol. 35, 11183–11191 (2014). https://doi.org/10.1007/s13277-014-2422-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-014-2422-y